CD274 and colorectal neoplasm: The patient did not have poor prognostic factors, such as a poor performance status, primary colorectal tumors, an elevated platelet count, or elevated lactate dehydrogenase levels [7], and nivolumab can be used regardless of tumor PD-L1 expression [12].